{"type":"rich","version":"1.0","title":"Podcast with Dr. Laurence Buisseret about first-line chemoimmunotherapy with durvalumab, paclitaxel, and carboplatin with or without the anti-CD73 antibody oleclumab to treat advanced or metastatic triple-negative breast cancer","author_name":"Ariez Publishing","author_url":null,"provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/ariez-publishing/podcast-with-dr-laurence-buisseret-about-maintenan/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"Podcast with Dr. Laurence Buisseret about first-line chemoimmunotherapy with durvalumab, paclitaxel, and carboplatin with or without the anti-CD73 antibody oleclumab to treat advanced or metastatic triple-negative breast cancer\"></iframe>","width":600,"height":180}